Ginsenoside Rg1 Epigenetically Modulates Smad7 Expression in Liver Fibrosis via MicroRNA-152

• Published in: Journal of ginseng research Vol. 47; no. 4; pp. 534 - 542
• Main Authors: Zhang, Rongrong, Li, Xinmiao, Gao, Yuxiang, Tao, Qiqi, Lang, Zhichao, Zhan, Yating, Li, Chunxue, Zheng, Jianjian
• Format: Journal Article
• Language: English
• Published: Korea (South) Elsevier B.V 01.07.2023; 고려인삼학회; Elsevier
• Subjects: CCl4-induced fibrosis; Ginsenoside Rg1; MiRNA; 기타의약학; Cur; DNMT1; PTCH1; MiRNA; Ginsenoside Rg1; EMT; ECM; CCl4-induced fibrosis; 5-Aza; α-SMA; MiR-152; UTR; CCl4; Edu; TGF-β; MiRNAs; HSCs; MRNA; MiR-NC; CCl₄-induced fibrosis
• DOI: 10.1016/j.jgr.2022.12.005
• ISSN: 1226-8453

Ginsenoside Rg1, a bioactive component of Ginseng, has demonstrated anti-inflammatory, anti-cancer, and hepatoprotective effects. It is known that the epithelial–mesenchymal transition (EMT) plays a key role in the activation of hepatic stellate cells (HSCs). Recently, Rg1 has been shown to reverse liver fibrosis by suppressing EMT, although the mechanism of Rg1-mediated anti-fibrosis effects is still largely unclear. Interestingly, Smad7, a negative regulator of the transforming growth factor β (TGF-β) pathway, is often methylated during liver fibrosis. Whether Smad7 methylation plays a vital role in the effects of Rg1 on liver fibrosis remains unclear. Anti-fibrosis effects were examined after Rg1 processing in vivo and in vitro. Smad7 expression, Smad7 methylation, and microRNA-152 (miR-152) levels were also analyzed. Rg1 significantly reduced the liver fibrosis caused by carbon tetrachloride, and reduced collagen deposition was also observed. Rg1 also contributed to the suppression of collagenation and HSC reproduction in vitro. Rg1 caused EMT inactivation, reducing Desmin and increasing E-cadherin levels. Notably, the effect of Rg1 on HSC activation was mediated by the TGF-β pathway. Rg1 induced Smad7 expression and demethylation. The over-expression of DNA methyltransferase 1 (DNMT1) blocked the Rg1-mediated inhibition of Smad7 methylation, and miR-152 targeted DNMT1. Further experiments suggested that Rg1 repressed Smad7 methylation via miR-152-mediated DNMT1 inhibition. MiR-152 inhibition reversed the Rg1-induced promotion of Smad7 expression and demethylation. In addition, miR-152 silencing led to the inhibition of the Rg1-induced EMT inactivation. Rg1 inhibits HSC activation by epigenetically modulating Smad7 expression and at least by partly inhibiting EMT. [Display omitted]